# FDA Inspection 1174620 - Esperion - June 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/esperion/635c5352-841c-447d-902f-0ad3f43bb075
Source feed: FDA_Inspections

> FDA Inspection 1174620 for Esperion on June 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174620
- Company Name: Esperion
- Inspection Date: 2022-06-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1099175 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/esperion/2646faaa-0494-4855-a29e-ac33b4a3b2d4)

Company: https://www.keypedia.com/companies/esperion/38e07824-a42d-47e7-a8e4-6070ad6cf993

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c